Quick summary: CPNP cosmetic notification is an electronic submission made through the European Commission’s Cosmetic Products Notification Portal. The responsible person gathers product and safety-related information, submits the Article 13 notification before market placement, supplies the original label and a reasonably legible packaging photograph when the product is placed on the market, and keeps required information current. Notification does not constitute product approval.
For an OEM or private-label skincare project, the practical challenge is keeping the portal record aligned with the formula, label and responsible person. A supplier’s generic statement that it “has CPNP” cannot establish that your particular product has been notified correctly.
How does CPNP cosmetic notification work in practice?
The workflow starts with compliance decisions, not data entry. Under Regulation (EC) No 1223/2009, the responsible person must ensure that applicable cosmetic requirements are satisfied. A qualified safety assessment and cosmetic product safety report must be completed before market placement. The product information file must be accessible to the relevant authority.
The Commission describes CPNP as a free online notification system. Its information supports competent authorities’ market surveillance and poison centres’ medical work. Once a product is notified through CPNP, the Commission says no further national notification within the EU is needed. This does not remove other applicable obligations.
Step 1: Confirm the product and responsible person
First confirm that the product is a cosmetic under the EU framework. Intended use, presentation and claims matter; a formula alone does not settle a borderline classification. Confirm the EU-established responsible person for the specific supply arrangement before preparing the portal record.
For imported cosmetics, the importer is normally the responsible person for the particular product it places on the market. Another EU-established person may be designated through a written mandate accepted in writing. A distributor can become the responsible person when marketing a product under its own name or trademark or making a relevant modification. Assess the actual arrangement instead of assigning responsibility based only on job titles.
Step 2: Assemble consistent product information
Article 13 requires information including the product category and identifying names, the responsible person’s name and address where the file is accessible, the country of origin for imports, the Member State of intended placement and a contact person. It also requires specified nanomaterial and CMR substance information where relevant, and a frame formulation enabling prompt and appropriate medical treatment.
| Input | Practical check | Source owner |
|---|---|---|
| Product identity | Names and category match the commercial product | Brand and responsible person |
| Formula information | Submission data corresponds to the assessed version | Manufacturer and responsible person |
| Responsible person | Entity, address and file access are confirmed | Responsible person |
| Label and packaging | Original label and legible product photograph are controlled | Brand and packaging team |
Agree who will provide each item, who checks it and who controls changes. An INCI list, safety data sheet or factory certificate alone is not the complete preparation package. Request the information needed for the actual product and its intended use.
Step 3: Submit through the official portal
The responsible person uses the official CPNP access and guidance provided by the Commission. Review the live portal instructions for account access and submission details because interface steps can change. The Article 13(1) information must be notified before placing the product on the market.
Article 13(2) separately states that the original labelling and, where reasonably legible, a photograph of the corresponding packaging must be notified when the product is placed on the market. Plan final artwork and product photography early enough to satisfy that duty. Do not describe receipt of a portal record as an EU safety certificate.
Step 4: Check special routes before setting the launch date
Cosmetics containing nanomaterials can require additional notification under Article 16, generally six months before placement, subject to the provision’s scope and exceptions. This is separate from ordinary Article 13 notification. The responsible person should assess whether the ingredient and use fall within those rules before committing to launch.
Certain distributors also have notification duties when, on their own initiative, they translate labelling to meet national requirements for a product already placed in another Member State. Translation alone does not automatically make a distributor the responsible person; the roles and notification duties must be assessed separately.
| Market scope | CPNP planning point | Boundary |
|---|---|---|
| EU cosmetic market placement | Apply the responsible-person and Article 13 framework | Notification is one compliance duty |
| Another EU Member State | Check label language and relevant distributor obligations | Do not assume all local duties disappear |
| Markets outside the EU | Assess the destination’s own rules | CPNP is not a worldwide registration |
Step 5: Preserve evidence and manage updates
Retain an internal link between the notification record, product identifier, formula version, safety report and final artwork. Article 13(7) requires specified information to be updated without delay when it changes. Build a change-control review into reformulations, name changes, packaging updates and responsible-person changes rather than treating notification as a one-time task.
The product information file has its own retention requirement: ten years after the last batch is placed on the market. Keeping a portal reference does not replace that file, manufacturing records or a process for handling serious undesirable effects.
Buyer checklist before launch
- Confirm the exact product identity and intended EU market.
- Document the responsible person and any necessary written mandate.
- Confirm the safety report, product information file and approved artwork.
- Check ordinary notification and any additional nanomaterial timing.
- Reconcile the notification with the product actually supplied.
- Assign responsibility for later updates and compliance enquiries.
Frequently asked questions
Is the Commission’s CPNP portal free?
Yes. The Commission describes the portal as free. Charges from consultants or responsible-person providers are separate commercial service fees.
Does CPNP approve the product?
No. Notification supplies required information; it does not substitute for safety assessment or the responsible person’s compliance duties.
Can the manufacturer handle notification?
Practical preparation can involve the manufacturer, but the legal role and submission responsibility must be clear. An overseas factory is not automatically an EU responsible person.
Does every label translation require a new responsible person?
No. Translation alone is excluded from the modification rule that makes a distributor the responsible person, although a particular translation scenario can trigger distributor notification duties.
Can the record be left unchanged after reformulation?
Do not assume so. Review safety, the file, labelling and notification together; Article 13 requires specified changed information to be updated without delay.
Plan the manufacturer-to-brand handover
For a project with MOOYAM, agree the target market, formula documentation, artwork versions and responsible-person handover before production. Ask for a product-specific documentation checklist; confirm EU legal decisions with the appointed responsible person and qualified safety assessor.
Official sources
- European Commission: Cosmetic Products Notification Portal
- European Commission: cosmetics legislation overview
- EUR-Lex: Regulation (EC) No 1223/2009, consolidated 18 May 2026 — especially Articles 4, 10, 11, 13 and 16.
Sources checked 22 September 2026. This EU-focused explanation is general information; product-specific obligations require assessment against the applicable rules.